Literature DB >> 178472

Circulating antibody to renal collecting ducts in patients with hepatoma or renal-cell carcinoma.

A P Forbes, J R Lake, K J Bloch.   

Abstract

An anti-kidney antibody was demonstrated by the indirect immunofluorescence method in the serum of patients with primary tumours of the liver or kidney. The distribution of fluorescence in rabbit kidney was consistent with that of antibody to collecting ducts. The anti-collecting duct antibody (anti-CDA) could be absorbed from serum by normal adult rabbit or human kidney tissue and by one of three specimens of renal-cell carcinoma tissue. Anti-CDA differed from anti-mitochondrial antibodies and from anti-liver/kidney microsomal antibody in the pattern of fluorescent staining obtained with rabbit kidney. Two-hundred sera from patients with cancer and other diseases and forty-three from healthy hospital personnel were tested for anti-CDA. Eleven of the twenty-five positive sera were from patients with primary cancer of the liver or urinary tract, and all but six of the remainder were from patients with tumours involving the liver or with liver disorders that may be associated with nodular hyperplasia or tumour.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 178472      PMCID: PMC1538439     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS.

Authors:  J G WALKER; D DONIACH; I M ROITT; S SHERLOCK
Journal:  Lancet       Date:  1965-04-17       Impact factor: 79.321

2.  [Antibodies against a fetorenal antigen in hepatitis B patients, in patients with kidney tumors, and in healthy individuals].

Authors:  G S Kistler; W Sonnabend
Journal:  Schweiz Med Wochenschr       Date:  1974-04-06

3.  Microsomal antibodies in active chronic hepatitis and other disorders.

Authors:  M Rizzetto; G Swana; D Doniach
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

4.  A tumor-associated antigen in human nephroblastomas.

Authors:  P Burtin; M C Gendron
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

5.  Demonstration of cell-mediated immunity to human neoplasms of various histological types.

Authors:  I Hellström; K E Hellström; H O Sjögren; G A Warner
Journal:  Int J Cancer       Date:  1971-01-15       Impact factor: 7.396

6.  Possible association between benign hepatomas and oral contraceptives.

Authors:  J K Baum; J J Bookstein; F Holtz; E W Klein
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

7.  Antimitochondrial antibodies in jaundice following drug administration.

Authors:  M Rodriguez; F Paronetto; F Schaffner; H Popper
Journal:  JAMA       Date:  1969-04-07       Impact factor: 56.272

8.  [Detection of tumorantigens of hypernephroma (author's transl)].

Authors:  K H Bichler; C Kirchner; F Porzsolt
Journal:  Urol Int       Date:  1973       Impact factor: 2.089

9.  Tumour-distinctive cellular immunity to renal carcinoma.

Authors:  J Stjernswärd; L E Almgård; S Franzén; T von Schreeb; L B Wadström
Journal:  Clin Exp Immunol       Date:  1970-06       Impact factor: 4.330

10.  Non-organ-specific cytoplasmic antibodies detected by immunofluorescence.

Authors:  D Doniach; H L Lindqvist; P A Berg
Journal:  Int Arch Allergy Appl Immunol       Date:  1971
  10 in total
  1 in total

Review 1.  Immunologically mediated lesions of kidney tubules and interstitium in laboratory animals and in man.

Authors:  J R Brentjens; B Noble; G A Andres
Journal:  Springer Semin Immunopathol       Date:  1982
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.